We are live on ! Find out more
KOSP

K O S PHARMACEUTICALS INC
KOSP

Delisted

KOSP was delisted on the 14th of December, 2006.

Back to rankings

1 hedge funds and large institutions have $63K invested in K O S PHARMACEUTICALS INC in 2025 Q4 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more capital invested

Capital invested by funds: $58.3K → $63K (+$4.71K)

0% more funds holding

Funds holding: 1 → 1 (0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
RWM
RMG Wealth Management
Wisconsin
+$12.3K

Top Sellers

No sellers this quarter

KOSP Hedge Fund Activity: Q4 2025 in Review

1 of the 8,267 institutional investors tracked by Wall St. Rank reported a position in K O S PHARMACEUTICALS INC (KOSP) for Q4 2025, worth a combined $63K — up 8.1% from $58.3K a quarter earlier.

Fund positioning in KOSP was balanced in Q4 2025: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.

The largest buyer was RMG Wealth Management, adding an estimated $12.3K.

  • 1 institutional investor held K O S PHARMACEUTICALS INC (KOSP) as of Q4 2025, unchanged from Q3 2025.
  • Funds reported $63K of K O S PHARMACEUTICALS INC stock for Q4 2025, up 8.1% quarter-over-quarter.
  • 0 funds opened new K O S PHARMACEUTICALS INC positions in Q4 2025 and 0 closed out.
  • The largest K O S PHARMACEUTICALS INC buyer in Q4 2025 was RMG Wealth Management, an estimated $12.3K added.

Based on aggregated 13F filings for Q4 2025.